Immunomodulation by thalidomide and thalidomide analogues

被引:147
作者
Corral, LG [1 ]
Kaplan, G [1 ]
机构
[1] Celgene Corp, Warren, NJ USA
关键词
D O I
10.1136/ard.58.2008.i107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:107 / 113
页数:7
相关论文
共 81 条
  • [1] HIV ENHANCER ACTIVITY PERPETUATED BY NF-KAPPA-B INDUCTION ON INFECTION OF MONOCYTES
    BACHELERIE, F
    ALCAMI, J
    ARENZANASEISDEDOS, F
    VIRELIZIER, JL
    [J]. NATURE, 1991, 350 (6320) : 709 - 712
  • [2] Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
    Baert, FJ
    D'Haens, GR
    Peeters, M
    Hiele, MI
    Schaible, TF
    Shealy, D
    Geboes, K
    Rutgeerts, PJ
    [J]. GASTROENTEROLOGY, 1999, 116 (01) : 22 - 28
  • [3] Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent
    Bauer, KS
    Dixon, SC
    Figg, WD
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 55 (11) : 1827 - 1834
  • [4] The importance of local mucosal HIV-specific CD8+ cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12
    Belyakov, IM
    Ahlers, JD
    Brandwein, BY
    Earl, P
    Kelsall, BL
    Moss, B
    Strober, W
    Berzofsky, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (12) : 2072 - 2081
  • [5] Berenson JR, 1999, SEMIN HEMATOL, V36, P9
  • [6] ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF INTERLEUKIN-12 AGAINST MURINE TUMORS
    BRUNDA, MJ
    LUISTRO, L
    WARRIER, RR
    WRIGHT, RB
    HUBBARD, BR
    MURPHY, M
    WOLF, SF
    GATELY, MK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) : 1223 - 1230
  • [7] BUSLMANN JE, 1999, J IMMUNOL, V162, P4373
  • [8] EXCITATION OF AREA POSTREMA NEURONS BY TRANSMITTERS, PEPTIDES, AND CYCLIC-NUCLEOTIDES
    CARPENTER, DO
    BRIGGS, DB
    KNOX, AP
    STROMINGER, N
    [J]. JOURNAL OF NEUROPHYSIOLOGY, 1988, 59 (02) : 358 - 369
  • [9] Castilla EE, 1996, TERATOLOGY, V54, P273, DOI 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO
  • [10] 2-#